Source: ALL
| Variant | Gene | Risk Allele | Score vda | Association Type | Original DB | Sentence supporting the association | PMID | PMID Year | ||
|---|---|---|---|---|---|---|---|---|---|---|
|
0.020 | GeneticVariation | BEFREE | Rottlerin also enhanced the cytotoxic effect of imatinib in leukemic cells from patients with CML blast crisis and Ph-positive ALL or a cell line expressing the imatinib-resistant E255K BCR/ABL mutant. | 17130834 | 2007 |
||||
|
0.020 | GeneticVariation | BEFREE | We identified for the first time the mutation Glu255Lys in STI571-naive leukemic samples of Ph+ ALL patients. | 12663457 | 2003 |